CUSIP
No. - N/A
|
13D
|
Page
2 of 11
|
(1)
|
Name
of Reporting Persons/IRS Identification Nos. of Above Persons (Entities
Only)
Dr.
Terence H. Matthews
|
||||
(2)
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
(a) x
(b)
r
|
|||
(3)
|
SEC
Use Only
|
||||
(4)
|
Source
of Funds (See Instructions)
N/A
|
||||
(5)
|
Check
if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or
2(e).
|
r
|
|||
(6)
|
Citizenship
or Place of Organization
Canada
|
||||
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With
|
(7)
|
Sole
Voting Power
11,441,175
|
|||
(8)
|
Shared
Voting Power
163,345,403
|
||||
(9)
|
Sole
Dispositive Power
11,441,175
|
||||
(10)
|
Shared
Dispositive Power
163,345,403
|
||||
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
174,786,578
|
||||
(12)
|
Check
Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
(See
Instructions)
|
r
|
|||
(13)
|
Percent
of Class Represented by Amount in Row (11)
77.8%
|
||||
(14)
|
Type
of Reporting Person (See Instructions)
IN
|
CUSIP
No. - N/A
|
13D
|
Page
3 of 11
|
(1)
|
Name
of Reporting Persons/IRS Identification Nos. of Above Persons
(Entities
Only)
Wesley
Clover Corporation
|
||||
(2)
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
(a)x
(b)r
|
|||
(3)
|
SEC
Use Only
|
||||
(4)
|
Source
of Funds (See Instructions)
N/A
|
||||
(5)
|
Check
if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or
2(e).
|
r
|
|||
(6)
|
Citizenship
or Place of Organization
Canada
|
||||
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With
|
(7)
|
Sole
Voting Power
0
|
|||
(8)
|
Shared
Voting Power
163,345,403
|
||||
(9)
|
Sole
Dispositive Power
0
|
||||
(10)
|
Shared
Dispositive Power
163,345,403
|
||||
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
163,345,403
|
||||
(12)
|
Check
Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
(See
Instructions)
|
r
|
|||
(13)
|
Percent
of Class Represented by Amount in Row (11)
76.6%
|
||||
(14)
|
Type
of Reporting Person (See Instructions)
CO
|
CUSIP
No. - N/A
|
13D
|
Page 4
of 11
|
(1)
|
Name
of Reporting Persons/IRS Identification Nos. of Above Persons
(Entities
Only)
Celtic
Tech Jet Limited
|
||||
(2)
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
(a) x
(b) r
|
|||
(3)
|
SEC
Use Only
|
||||
(4)
|
Source
of Funds (See Instructions)
N/A
|
||||
(5)
|
Check
if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or
2(e).
|
r
|
|||
(6)
|
Citizenship
or Place of Organization
Canada
|
||||
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With
|
(7)
|
Sole
Voting Power
0
|
|||
(8)
|
Shared
Voting Power
4,555,169
|
||||
(9)
|
Sole
Dispositive Power
0
|
||||
(10)
|
Shared
Dispositive Power
4,555,169
|
||||
(11)
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
4,555,169
|
||||
(12)
|
Check
Box if the Aggregate Amount in Row (11) Excludes Certain
Shares
(See
Instructions)
|
r
|
|||
(13)
|
Percent
of Class Represented by Amount in Row (11)
2.1%
|
||||
(14)
|
Type
of Reporting Person (See Instructions)
CO
|
Item
4.
|
Purpose
of Transaction
|
Item
5.
|
Interest
in Securities of the
Issuer
|
Reporting
Person
|
Aggregate
Number of
Shares
Beneficially
Owned
|
Percentage
of
Outstanding
Common
Shares (1)
|
||
Dr.
Matthews
|
174,786,578
(2)(4)
|
77.8%
|
||
Wesley
Clover
|
163,345,403
(3)(4)
|
76.6%
|
||
Celtic
|
4,555,169
|
2.1%
|
(1)
|
Calculated
based on 213,272,400 Common Shares outstanding as of August 31,
2007. However, for purposes of computing Dr. Matthews'
percentage ownership, the number of outstanding Common Shares is
deemed to
include all Common Shares that Dr. Matthews has a right to acquire
beneficial ownership of within 60 days of the date of this Statement
pursuant to Rule 13d-3 under the Exchange
Act.
|
(2)
|
Calculated
based on (i) 158,790,234 Common Shares owned by Wesley Clover, (ii)
4,555,169 Common Shares owned by Celtic, (iii)
1,143,404 Common Shares subject to options and warrants held by Dr.
Matthews that are currently exercisable or exercisable within 60
days, and
(iv) 13,500 Class 1 Shares (as defined below) held by Dr. Matthews
that
were convertible into 10,297,771 Common Shares at August 31,
20071
|
(3)
|
Calculated
based on (i) 158,790,234 Common Shares owned by Wesley Clover and
(ii)
4,555,169 Common Shares owned by
Celtic.
|
(4)
|
Dr.
Matthews owns 100% of Wesley Clover and Wesley Clover owns 100% of
Celtic. Pursuant to Rule 13d-3 under the Exchange Act, Dr.
Matthews may be deemed the beneficial owner of all of the Common
Shares
beneficially owned by both Wesley Clover and Celtic and Wesley Clover
may
be deemed the beneficial owner of all of the Common Shares owned
by
Celtic.
|
1
|
The
Class 1 Shares are subject to an 8% accretion rate which would
result in
the 13,500 Class 1 Shares being increased to 13,725 Class 1 Shares
at
October 31, 2007 which would be convertible into 10,428,539 Common
Shares
at such date.
|
Item
6.
|
Contracts,
Arrangements, Understandings or Relationships With
Respect
to Securities of the
Issuer
|
2
|
The
Articles of Amendment establishing the terms of the Class 1 Shares
are
attached as Schedule B to the Shareholders Agreement (attached
to this
Schedule as Exhibit 11).
|
Item
7.
|
Material
to be Filed as
Exhibits
|
Exhibit
1:
|
Joint
Filing Agreement, dated as of September 28, 2007, among Dr. Terence
H.
Matthews, Wesley Clover Corporation and Celtic Tech Jet
Limited.
|
Exhibit
9:
|
Amended
and Restated Warrant Repurchase, Voting and Conversion Agreement,
dated
August 15, 2007, between Wesley Clover Corporation, Dr. Terence H.
Matthews, Celtic Tech Jet Limited and Mitel Networks Corporation
(the
"Warrant Repurchase, Voting and Conversion Agreement").
|
Exhibit
10:
|
Termination
Agreement, dated August 16, 2007, between Mitel Networks Corporation,
EdgeStone, Zarlink Semiconductor Inc., Power Technology Investment
Corporation, Wesley Clover Corporation, Dr. Terrance H. Matthews
and
Celtic Tech Jet Limited (the "Termination Agreement").
|
Exhibit
11:
|
Shareholders
Agreement, dated August 16, 2007, between Mitel Networks Corporation,
EdgeStone, Power Technology Investment Corporation, Dr. Terrance
H.
Matthews, Wesley Clover Corporation, Celtic Tech Jet Limited,
Francisco Partners, and Morgan Stanley Principal Investments, Inc.
(the
"Shareholders Agreement").
|
Exhibit
12:
|
Registration
Rights Agreement, dated August 16, 2007, between Mitel Networks
Corporation, Francisco Partners, Morgan Stanley Principal Investments,
Inc., EdgeStone, Dr. Terrance H. Matthews, Wesley Clover Corporation,
and
Celtic Tech Jet Limited (the "Registration Rights
Agreement").
|
Exhibit
13:
|
Transfer
Agreement, dated May 14, 2007, between Wesley Clover Corporation
and Dr.
Terence H. Matthews (the "Warrant Transfer Agreement").
|
Exhibit
14:
|
Transfer
Agreement, dated May 14, 2007, between Terence H. Matthews and Wesley
Clover Corporation (the "Series B Shares Transfer
Agreement").
|
Exhibit
15:
|
Letter
Agreement, dated July 31, 2007, between Dr. Terence H. Matthews and
Mary
E. Mills (the "Letter Agreement").
|
By:
|
/s/
Dr. Terence H. Matthews
|
||
Name:
|
Dr.
Terence H. Matthews
|
WESLEY
CLOVER CORPORATION
|
|||
By:
|
/s/
Jose Medeiros
|
||
Name:
|
Jose
Medeiros
|
||
Title:
|
President
and Chief
Operating
Officer
|
CELTIC
TECH JET LIMITED
|
|||
By:
|
/s/
Jose Medeiros
|
||
Name:
|
Jose
Medeiros
|
||
Title:
|
President
|